AzTrials
AzTrials

Ankle FracturesPRO-MalleolNCT03107767

Study of Re-operation Rate After Introduction of Evidence Based Algorithm for the Treatment of Ankle Fractures

A study testing PRO-malleol algorithm in people with Ankle Fractures and Surgery, run by Hvidovre University Hospital at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

There is a high incidence of re-operations after surgery for ankle fractures. According to the Danish Fracture Database (DFDB) the re-operation rate, excluding hardware removal, is almost 10%. We are conducting a study on the efficacy of an evidence based algorithm for the treatment of ankle fractures. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ankle Fractures, Surgery, Syndesmotic Injuries
What is being tested?
PRO-malleol algorithm
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteDenmark
Study dates
1 Jun 2016to 1 Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All patients treated for ankle fractures at our institution during the study period are asked to participate in the study.

Who cannot join

  • Not speaking danish Not followed up at our institution Not mentally capable of filling out questionnaire

Trial locations and contacts

1 site in 1 country.

Denmark1 site, 1 recruiting
  • Hvidovre University Hospital

    Hvidovre, 2650

    Peter T Tengberg, MD, +4561663676, ptofttengberg@gmail.com

    Peter T Tengberg, MD, +4522971007, peter.toft.tengberg@regionh.dk

    Recruiting

Other trials in Denmark

About this study

Official title: The PRO-malleol Study

There is a high incidence of re-operations after surgery for ankle fractures. According to the Danish Fracture Database (DFDB) the re-operation rate, excluding hardware removal, is almost 10%.

We are conducting a study on the efficacy of an evidence based algorithm for the treatment of ankle fractures.

Read the detailed description

Treatment of ankle fractures is complex and includes assessment of fracture pattern, severity of soft-tissue involvement and general health- and functional status of the patients. Historically most fractures, undisplaced as well as displaced, were treated non-operatively with acceptable results but in recent years there is an increasing trend towards operative management of unstable fractures. Techniques for operative management of ankle fractures are varied and assessment of instability is mainly based on classic x-ray classification systems such as Lauge-Hansen or the AO that are difficult to reproduce[6].

We hypothesize that a standardized and evidence based approach to ankle fracture management will lead to a decrease in re-operation rate.

The aim of this study is to standardize the management of ankle fractures in our department, by introducing an algorithm based on best evidence present. We want to investigate:

  1. The effect of this algorithm on the re-operation rate of surgically treated ankle fractures in a two-year prospective observational setup with a minimum of one-year of follow-up.
  2. The need for surgery and functional outcome of patients with isolated lateral malleolus fractures in which the treatment is dictated by ankle stability assessed on weight bearing radiographs.
Being tested
PRO-malleol algorithm
Medical subject headings
Ankle Fractures, Ankle Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PRO-malleol algorithmProcedure or surgery

    An evidence based algorithm for ankle fractures

Study groups in NCT03107767
Study groupRoleWhat they receive
Prospective CohortActive comparatorThe prospective cohort following introduction of the evidence based algorithm for ankle fractures.
Receives: Procedure: PRO-malleol algorithm
Historical CohortNo interventionPatients treated before introduction of algorithm. Matched to prospective cohort for comparison

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in re-operation rate

    Change in re-operation rate following introduction of PRO malleol algorithm

    Measured: one year

  2. Rate of surgery for isolated lateral ankle fractures

    Rate of surgery for isolated lateral ankle fractures, following introduction of algorithm

    Measured: one year

Secondary outcomes (4)
  1. SF 36

    SF 36 before fracture and at 12 months

    Measured: day 0 and 12 months

  2. Ollerud Molander Ankle Score

    Measured: Before fracture, 6 weeks, 12 weeks and 1 year

  3. Forgotten Joint Score

    Before fracture, 6 weeks, 12 weeks and 1 year

    Measured: Before fracture, 6 weeks, 12 weeks and 1 year

  4. Rate of complications not requiring surgery

    DVT, Nerve damage,

    Measured: One year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Apr 2017
  2. Study start1 Jun 2016
  3. Primary completion1 Jun 2018 (estimated)
  4. Study completion1 Jun 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Sequential
Model description
A prospective cohort, following the introduction of an evidence based algorithm, will be compared to a matched historical cohort from the previous years.
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03107767
Sponsor's protocol ID
PRO-Malleol study
Acronym
PRO-Malleol
Status last verified
Apr 2017
First submitted
5 Apr 2017
Last updated
11 Apr 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data will be anonymized and openly shared with any who requests it, after study publication.

Questions about this trial

What is this clinical trial studying?

A study testing PRO-malleol algorithm in people with Ankle Fractures and Surgery, run by Hvidovre University Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in re-operation rate (time frame: one year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in